2004
DOI: 10.1016/j.mce.2004.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Activin isoforms signal through type I receptor serine/threonine kinase ALK7

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

8
85
1
1

Year Published

2005
2005
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 130 publications
(95 citation statements)
references
References 23 publications
8
85
1
1
Order By: Relevance
“…Upon ligand binding, one of the activin type II receptors (ActRII or ActRIIB) dimerizes with a type I receptor (ActRIA, ActRIB or activin receptorlike kinase 7), resulting in phosphorylation of the type I receptor by the type II receptor. 2,3 Although we and others have firmly established a neuroprotective role of activin in acute brain injury, [4][5][6] it remained unclear whether activin also influences the operation of neuronal circuits under physiological conditions. To explore the functions of activin in normal adult brain, we recently generated transgenic (tg) mice expressing a dominant-negative mutant of activin receptor IB (dnActRIB) under the control of the CaMKIIa promoter.…”
Section: Introductionmentioning
confidence: 99%
“…Upon ligand binding, one of the activin type II receptors (ActRII or ActRIIB) dimerizes with a type I receptor (ActRIA, ActRIB or activin receptorlike kinase 7), resulting in phosphorylation of the type I receptor by the type II receptor. 2,3 Although we and others have firmly established a neuroprotective role of activin in acute brain injury, [4][5][6] it remained unclear whether activin also influences the operation of neuronal circuits under physiological conditions. To explore the functions of activin in normal adult brain, we recently generated transgenic (tg) mice expressing a dominant-negative mutant of activin receptor IB (dnActRIB) under the control of the CaMKIIa promoter.…”
Section: Introductionmentioning
confidence: 99%
“…4 Activin A is a molecule with pleiotropic functions, which shares with TGF-b the SMAD2/3 canonical signaling pathway (reviewed by Shi and Massague 5 ) but uses distinct type II (ActRIIs) and type I (ALK2, ALK4 and ALK7) receptors. [6][7][8][9] The biological function of activins can be blocked by follistatin (FS), a glycoprotein that binds activin A with high affinity, functioning as a ligand trap. 10 On the other hand, inhibins are heterodimers formed by uncommon a-and b-subunits and exist in two isoforms, inhibin A (a/bA) and B (a/bB).…”
mentioning
confidence: 99%
“…Activin activities are mediated by heteromeric receptor complexes, consisting of type I (ActRIA/Alk2, ActRIB/Alk4, and Alk7) and type II (ActRII and ActRIIB) receptors, which are all serine/threonine kinases (Mathews and Vale, 1993;Tsuchida et al, 2004). In addition, activins bind to the soluble glycoprotein follistatin that inhibits activin action (Nakamura et al, 1990).…”
mentioning
confidence: 99%